
Ion Biotechnology
Ion Biotechnology (USA), Inc. was incorporated in Texas in 2017. The company is applying metal ion technology as a potential cancer therapeutic. We are working with several of the world’s leading medicinal inorganic chemists to mature the technology in preparation for preclinical development.
Dennis Stone, CEO and Director Holt Smith, General Counsel and Director Alan Bailey, CFO and Director Dr. Debbie Crans, Chemistry and Biochemistry Advisor Dr. Maria Contel, Chemistry Advisor Dr. Michael Weickert, Business Advisor